APA (7th ed.) Citation

Qin, X., Ruan, H., Yuan, L., & Lin, L. (2023). Colorectal cancer tumor stem cells mediate bevacizumab resistance through the signal IL-22-STAT3 signaling pathway. 3 Biotech, 13(10), 1. https://doi.org/10.1007/s13205-023-03742-5

Chicago Style (17th ed.) Citation

Qin, Xiaoning, Hongxun Ruan, Liqing Yuan, and Lin Lin. "Colorectal Cancer Tumor Stem Cells Mediate Bevacizumab Resistance Through the Signal IL-22-STAT3 Signaling Pathway." 3 Biotech 13, no. 10 (2023): 1. https://doi.org/10.1007/s13205-023-03742-5.

MLA (9th ed.) Citation

Qin, Xiaoning, et al. "Colorectal Cancer Tumor Stem Cells Mediate Bevacizumab Resistance Through the Signal IL-22-STAT3 Signaling Pathway." 3 Biotech, vol. 13, no. 10, 2023, p. 1, https://doi.org/10.1007/s13205-023-03742-5.